Faruqi & Faruqi, LLP: Investigating Potential Claims Against ModivCare, Inc.
Faruqi & Faruqi, LLP, a reputed national securities law firm, is currently looking into potential securities fraud claims against ModivCare, Inc. (MODV). The investigation comes after a federal securities class action was filed against the Company. If you’re an investor who has suffered losses exceeding $50,000 in ModivCare between November 3, 2022, and May 3, 2023, you may be eligible to take part in this class action. To learn more about your legal rights and options, contact Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330, ext. 1310.
About ModivCare, Inc.
ModivCare, Inc. is a healthcare services company that provides post-acute care services, including home health, hospice, and infusion services. The Company’s mission is to deliver high-quality, cost-effective healthcare services that improve patients’ lives and enable them to recover in the comfort of their own homes.
The Class Action Lawsuit
The federal securities class action against ModivCare alleges that the Company and certain of its executives made false and misleading statements regarding the Company’s business, operations, and financial condition. Specifically, the complaint alleges that the defendants failed to disclose material information related to the Company’s financial performance and business prospects. As a result, investors suffered significant losses when the truth came to light.
Impact on Individual Investors
If you’re an investor who purchased ModivCare securities between November 3, 2022, and May 3, 2023, and suffered losses exceeding $50,000, you may be able to recover your losses through the class action. By joining the class action, you’ll be part of a group of investors seeking compensation from the Company and its executives for their misrepresentations. The lead plaintiff will play a crucial role in the litigation, helping to shape the direction of the case and potentially receiving a larger share of any recovery.
Impact on the World
The fallout from securities fraud cases like the one against ModivCare can ripple through the financial markets and impact the broader economy. The discovery of material misstatements or omissions can lead to a loss of confidence in the Company and the industry as a whole. In turn, this can result in decreased investor interest, reduced stock prices, and increased volatility. Furthermore, securities fraud can also lead to regulatory action, fines, and stricter regulations, which can impact the entire industry.
Conclusion
If you’re an investor who has suffered losses exceeding $50,000 in ModivCare between November 3, 2022, and May 3, 2023, and would like to discuss your legal rights and options, contact Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330, ext. 1310. The deadline to seek the role of lead plaintiff in the federal securities class action is March 31, 2025. Don’t miss out on your opportunity to recover your losses and hold the Company and its executives accountable for their misrepresentations.
